AI impressive as a second set of eyes in colonoscopy (AIinHealthcare)
Researchers have developed a deep convolutional neural network that can identify colorectal polyps with 90% accuracy while ruling out 80% of false flags.
Scope Forward podcast – CEO of Bold Health (digital GI company) (Episode 26)
Listen to the interviews on the move! Praveen Suthrum’s conversations with GI leaders are now available via the Scope Forward podcast on Apple Podcasts, Spotify and elsewhere.
Private equity thriving in gastroenterology: 9 updates (Becker’s GI & Endoscopy)
Private equity has seen consistent success in gastroenterology, with firms like One GI acquiring at least three firms since the start of 2021.
OMERS buys Audax’s Gastro Health at mid-$900m valuation (PE Hub)
Being a first-mover is proving advantageous, with Audax one of the first private equity entrants in GI physician practice management as a result of its early 2016 investment.
Geneoscopy Announces Publication of Peer-Reviewed Article (BusinessWire)
The article reports high sensitivity of the company’s noninvasive, at-home diagnostic screening test to successfully detect colorectal neoplasms, in average-risk individuals within the intended use population for CRC.
Probiotics: A Review for Clinical Use (Gastroenterology & Endoscopy News)
Just how probiotics may affect various conditions is not completely understood, but several mechanisms have been proposed.
15 Need-to-Know Presentations From DDW 2021 (Medscape)
“We must consider raising our expectations for FIT-positive patients as well as looking for serrated lesions in mt-sDNA-positive patients.” – A Commentary by David A. Johnson, MD.
AI in GI startup Docbot funding $8.5M (Fierce Biotech)
Docbot aims to hit the ground running with a Series A cash infusion and a new CEO—and move forward with clinical trials of its real-time artificial intelligence programs for spotting potential cancers during colonoscopy.